Positive Psychology Based Psychoeducation for Psychological Flexibility and Perceived Stress in University Students

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHarran University

About this trial

This study will test whether an 8-week multi-component positive psychology-based psychoeducation program can reduce perceived stress and improve psychological flexibility among first-year undergraduate nursing students. Eligible students who provide informed consent will be randomly assigned to either an intervention group or a waitlist control group. The intervention group will attend weekly 60-75 minute psychoeducation sessions including brief psychoeducation, experiential exercises, shared reflection, and home practice assignments. The waitlist control group will continue their usual routine during the study period and will not receive any intervention before post-test assessment. Outcomes will be assessed at baseline and immediately after the 8-week program using the Perceived Stress Scale-14 and the Acceptance and Action Questionnaire-II.

Eligibility criteria

Qualifiers

Being a first-year undergraduate student in the Department of Nursing at Harran University.

Volunteering to participate in the study and providing informed consent.

Having no reading, comprehension, or communication difficulty that would prevent completion of the data collection tools.

Being 18 years of age or older.

Disqualifiers

Receiving regular psychotherapy or psychoeducation during the same academic period.

Having participated in a structured positive psychology-based psychoeducation or intervention program within the last 6 months.

Having a history of psychiatric hospitalization within the last 3 months or having an acute psychiatric crisis or instability that would make participation in the sessions inappropriate.

Trial design

Treatments tested in this trial

  • Positive Psychology Based Psychoeducation Program

Treatment groups

66 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators